PetDx OncoK9

PetDx OncoK9 is operated by PetDx, Inc., headquartered in La Jolla, California, United States. PetDx OncoK9 positions itself as a US veterinary diagnostic service offering liquid-biopsy cancer screening for dogs, sold via partner vets rather than direct-to-consumer. This 2026 review covers current tiers, anchor pricing, the 2025-2026 differentiator that matters right now, and the decision criteria a buyer should weigh before signing up.

Quick facts

• Operator: PetDx, Inc.
• Headquarters: La Jolla, California, United States
• Public-market status: Privately held
• Founded / launched: 2019
• Category: pets
• Current tiers: Per-test pricing / Vet partner pricing / Annual screening cadence
• Anchor price (2026): Approx USD 500-1,000 per test on the entry tier; Discounted institutional pricing on the main paid tier

What is PetDx OncoK9?

PetDx OncoK9 is a US veterinary diagnostic service offering liquid-biopsy cancer screening for dogs, sold via partner vets rather than direct-to-consumer. Its core surface delivers OncoK9 liquid-biopsy cancer screening test for dogs alongside blood-draw kit shipped to the veterinarian's clinic, with subscription billing handled through the operator's standard checkout. Customers pick a tier matching their usage: entry tiers test the product, the main paid tier covers everyday use, and higher tiers add depth such as next-generation sequencing analysis at PetDx labs.

Why choose PetDx OncoK9

Operator and category positioning

PetDx, Inc. runs PetDx OncoK9 from La Jolla, California, United States. The product fits the pets category by combining OncoK9 liquid-biopsy cancer screening test for dogs with blood-draw kit shipped to the veterinarian's clinic. Compared with broader generalist platforms, the operator's investment is concentrated in the pets workflow rather than spread thin across adjacent categories.

Plan structure and ecosystem

The tier ladder splits across 3 groups — Per-test pricing for entry-level use, Vet partner pricing as the standard everyday tier, and Annual screening cadence for power users or households / teams. Confirm live regional prices on the operator's site and check Subger's true-price tracker for PetDx OncoK9 for all-in renewal costs after taxes and FX conversion.

Pet health features and coverage

Beyond the headline experience, the operator's investment in next-generation sequencing analysis at PetDx labs and screening for over 30 cancer types sustains the subscription's value in 2026. PetDx scaled OncoK9 adoption through veterinary partnerships in 2024-2025 and continued expanding clinical evidence publications — this is the live 2025-2026 buying signal that distinguishes the current proposition from prior years.

PetDx OncoK9 features that matter in 2026

Highlights of the current feature set:

• OncoK9 liquid-biopsy cancer screening test for dogs
• blood-draw kit shipped to the veterinarian's clinic
• next-generation sequencing analysis at PetDx labs
• screening for over 30 cancer types
• results delivered via the vet partner
• follow-up recommendations from PetDx oncology team

Confirm specific feature availability on the operator's marketing pages before committing, since regional tier scopes and add-ons may vary.

PetDx OncoK9 pricing in 2026

Reference pricing for PetDx OncoK9 in 2026 typically looks like:

Subger pairs the list price with the actual all-in cost (taxes, FX, promotional anchors that step up at renewal):

PetDx OncoK9 apps and platform support

Surface availability varies by region and tier — confirm app availability and supported devices on the operator's site before subscribing.

Who PetDx OncoK9 fits

PetDx OncoK9 is a good match for the following buyers:

• Owners of older or high-cancer-risk dog breeds working with a participating veterinarian — the core audience for the product.
• The category-focused subscriber who specifically wants OncoK9 liquid-biopsy cancer screening test for dogs from a pets operator rather than a generalist platform.
• The household or team subscriber evaluating the tier ladder (Per-test pricing / Vet partner pricing / Annual screening cadence) and willing to pay up for blood-draw kit shipped to the veterinarian's clinic.
• The cross-device user who needs apps across the surfaces listed above plus a credible upgrade path.
• The price-aware shopper who tracks promotional anchors via Subger's true-price tracker and deals page before committing to annual billing.

Frequently asked questions

Who operates PetDx OncoK9 and where is it headquartered?

PetDx OncoK9 is operated by PetDx, Inc., headquartered in La Jolla, California, United States. Founding / launch context: 2019. The operator's public-market status is Privately held.

How much does PetDx OncoK9 cost in 2026?

Reference tiers in 2026 are Per-test pricing (Approx USD 500-1,000 per test) and Annual screening cadence (Annual screening for older or high-risk breeds). Regional pricing and promotional cycles vary — confirm the live price on the operator's site before committing.

Is there a free tier or free trial for PetDx OncoK9?

There is no perpetual free tier published for PetDx OncoK9; the operator may run periodic introductory trials. Check the live signup page for current promotions.

Where is PetDx OncoK9 available?

PetDx OncoK9 follows PetDx, Inc.'s licensing and service footprint anchored in La Jolla, California, United States. Confirm regional availability on the official site before subscribing.

What 2025-2026 features set PetDx OncoK9 apart right now?

PetDx scaled OncoK9 adoption through veterinary partnerships in 2024-2025 and continued expanding clinical evidence publications. The roadmap items most worth weighing are next-generation sequencing analysis at PetDx labs and screening for over 30 cancer types — these are the live buying signals to assess for 2026.

Which devices and platforms does PetDx OncoK9 support?

Coverage spans the surfaces shown in the platform table above. Current mobile and web apps are the recommended way to consume the service; older devices may be deprecated in successive releases.

How do I cancel PetDx OncoK9?

Cancel through the account or subscription settings on the surface where you bought the plan: the operator's website for direct subscriptions, the App Store or Google Play for in-app purchases, or the partner billing portal for bundled subscriptions. Subger's cancellation guide for PetDx OncoK9 walks through each route step-by-step.

Does PetDx OncoK9 offer a family, household or business plan?

Higher tiers (Annual screening cadence) typically add multi-profile, household or business seats. Entry tiers may restrict simultaneous usage. Confirm the per-tier seat or profile limit on the live pricing page.

Is PetDx OncoK9 worth it compared with category alternatives?

Value depends on three factors: the feature mix you'll actually use (see the features list above), the regional price after taxes (Subger's true-price tracker for PetDx OncoK9 reconciles the headline price with the actual all-in renewal cost), and the credibility of the operator's 2025-2026 roadmap. Weigh these together rather than relying on the headline price alone.

How can I track price changes for PetDx OncoK9?

Subger's renewal tracker for PetDx OncoK9 records list-price changes plus promotional anchors over time. Pair it with the deals page for current discount codes and the promo codes page for stackable savings at signup.

Get started with PetDx OncoK9

Confirm the current regional price on the operator's site, choose the tier that matches your usage (Per-test pricing, Vet partner pricing are the most common starting points), and check Subger's deals page for PetDx OncoK9 for promotional anchors before completing checkout. Track the subscription's true renewal cost with the true-price tracker once you're signed up.

Related Subger guides

• Cancel PetDx OncoK9 guide
• Latest PetDx OncoK9 deals
• PetDx OncoK9 promo codes
• PetDx OncoK9 true price and renewal tracker
• Browse the pets category hub
• All services on Subger